Oncology research and treatment
Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer.
Axel Muendlein, Eva Maria Brandtner, Christine Heinzle, Kathrin Geiger, Andreas Leiherer, Magdalena Benda-Beck, Patrick Reimann, Tobias Dechow, Thomas Decker
Published: 202610.1159/000550608
Abstract
BACKGROUND & OBJECTIVE: Leucine-rich α-2 glycoprotein 1 (LRG1) is a multifunctional pro-inflammatory signaling molecule that has been proposed as a promising biomarker and potential therapeutic target across various types of cancer. Prospective studi…
Preview only. Read the full abstract at the source